Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology

被引:1
|
作者
Corrado, Alda [1 ]
Aceto, Romina [1 ,2 ]
Miglietta, Simona [3 ]
Silvestri, Roberto [1 ]
Dell'Anno, Irene [1 ]
Lepori, Irene [4 ]
Ricci, Benedetta [5 ]
Romei, Cristina [6 ]
Giovannoni, Roberto [1 ]
Poliseno, Laura [4 ]
Evangelista, Monica [4 ]
Vitiello, Marianna [4 ]
Cipollini, Monica [1 ]
Elisei, Rossella [6 ]
Landi, Stefano [1 ]
Gemignani, Federica [1 ]
机构
[1] Univ Pisa, Dept Biol, Genet Unit, Via Derna 1, I-56126 Pisa, Italy
[2] Humanitas Clin & Res Ctr IRCCS, Via Manzoni 56, I-20089 Milan, Italy
[3] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Via Olgettina 60, I-20132 Milan, Italy
[4] CNR, Inst Clin Physiol IFC, Via Giuseppe Moruzzi 1, I-56124 Pisa, Italy
[5] Fdn IRCCS Ist Neurol Carlo Besta, Via Celoria 11, I-20133 Milan, Italy
[6] Univ Pisa, Dept Clin & Expt Med, Endocrine Unit, Via Paradisa 2, I-56124 Pisa, Italy
关键词
CRISPR/Cas9; Knock-in; Human cell lines; Single base DNA editing; Double nickase strategy;
D O I
10.1007/s13205-023-03878-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The use of CRISPR/Cas9 system has rapidly grown in the last years. Here, the optimization of gene editing of a single-nucleotide polymorphism in a human non-malignant somatic cell line of thyrocytes (Nthy-Ori) was described highlighting strategies for overcoming the problems concerning the delivery and off-targets. We employed both lentivirus and chemical lipids as delivery agents and two strategies for creating the double-strand breaks (DSB). The former induced a DSB by a classical Cas9 nuclease (standard strategy), while the second one employed a modified Cas9 creating a single-strand break (SSB). The knock-in was carried out using a single-stranded donor oligonucleotide or the HR410-PA donor vector (HR). The desired cells could be obtained by combining the double nickase system with the HR vector transfected chemically. This result could be due to the type of DSB, likely processed mainly by non-homologous end joining when blunt (standard strategy) and by HR when overhanging (double nickase). Our results showed that the double nickase is suitable for knocking-in the immortalized Nthy-Ori cell line, while the standard CRISPR/Cas9 system is suitable for gene knock-out creating in/del mutations.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Prospects and challenges of CRISPR/Cas9 gene-editing technology in cancer research
    Ning, Li
    Xi, Jiahui
    Zi, Yin
    Chen, Min
    Zou, Qingjian
    Zhou, Xiaoqing
    Tang, Chengcheng
    CLINICAL GENETICS, 2023, 104 (06) : 613 - 624
  • [32] Targeting SIVmac239 genome with CRISPR/Cas9 gene editing technology
    Mancuso, Pietro
    Young, Won-Bin
    Nawrat, Dominika
    Burdo, Tricia H.
    MacLean, Andrew
    Kaminski, Rafal
    Khalili, Kamel
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2018, 13 : S52 - S52
  • [33] Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases
    Sundaresan, Yogapriya
    Yacoub, Sam
    Kodati, Bindu
    Amankwa, Charles E.
    Raola, Akash
    Zode, Gulab
    FEBS JOURNAL, 2023, 290 (22) : 5248 - 5269
  • [34] CRISPR/CAS9 GENE EDITING TO BLOCK MALARIA TRANSMISSION
    Simoes, Maria
    Dong, Yuemei
    Dimopoulos, George
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 262 - 262
  • [35] CRISPR/Cas9 gene editing for genodermatoses: progress and perspectives
    Naso, Gaetano
    Petrova, Anastasia
    EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (03) : 313 - 326
  • [36] CRISPR/Cas9 gene editing therapies for cystic fibrosis
    Graham, Carina
    Hart, Stephen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (06) : 767 - 780
  • [37] The enhancement of CRISPR/Cas9 gene editing using metformin
    Rollins, Jaedyn L.
    Hall, Raquel M.
    Lemus, Clara J.
    Leisten, Lauren A.
    Johnston, Jennifer M.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2023, 35
  • [38] CRISPR/CAS9 GENE EDITING APPLICATIONS IN CARDIOVASCULAR DISEASE
    Khouzam, J.
    Khouzam, R.
    Tivakaran, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 423 - 424
  • [39] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
    Xu, Sen
    Pham, Thinh
    Neupane, Swatantra
    MARINE LIFE SCIENCE & TECHNOLOGY, 2020, 2 (01) : 1 - 5
  • [40] Therapeutic gene editing in haematological disorders with CRISPR/Cas9
    Jensen, Trine I.
    Axelgaard, Esben
    Bak, Rasmus O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 821 - 835